US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Veraxa Biotech Holding AG

1.46

-0.0100-0.68%

Post-market: 1.460.00000.00%16:10 EDT

Volume:16.38K

Turnover:24.11K

Market Cap:206.46M

PE:6.82

High:1.52

Open:1.50

Low:1.45

Close:1.47

52wk High:27.36

52wk Low:1.27

Shares:141.41M

Float Shares:40.96M

Volume Ratio:0.27

T/O Rate:0.04%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.2142

EPS(LYR):-5.8037

ROE:-871.42%

ROA:-49.99%

PB:-10.77

PE(LYR):-0.25

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

VERAXA Biotech (NASDAQ: VRXA) Adds Capital Markets Veteran as CFO While Advancing BiTAC Oncology Pipeline

VERAXA Biotech (NASDAQ: VRXA) Building a New Approach to Precision Cancer Therapy

Veraxa Biotech Files Initial Beneficial Ownership Statement for CFO Raju Sudir Willener

Veraxa Biotech Names Raju Willener as CFO

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/VRXA"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VRXA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRXA\",,,,,undefined,":{"symbol":"VRXA","market":"US","secType":"STK","nameCN":"Veraxa Biotech Holding AG","latestPrice":1.46,"timestamp":1789761600000,"preClose":1.47,"halted":0,"volume":16375,"hourTrading":{"tag":"盘后","latestPrice":1.46,"preClose":1.46,"latestTime":"16:10 EDT","volume":8,"amount":11.68,"timestamp":1789762204697,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.00680272108843538,"floatShares":40957496,"shares":141407813,"eps":0.2142,"marketStatus":"Market Closed","change":-0.01,"latestTime":"09-18 16:00:00 EDT","open":1.5,"high":1.5152,"low":1.45,"amount":24112,"amplitude":0.044354,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.2142,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.47,"preHourTrading":{"tag":"盘前","latestPrice":1.47,"preClose":1.47,"latestTime":"09:29 EDT","volume":187,"amount":277.9395025,"timestamp":1789738199018,"change":0,"changeRate":0,"amplitude":0.069456},"postHourTrading":{"tag":"盘后","latestPrice":1.46,"preClose":1.46,"latestTime":"16:10 EDT","volume":8,"amount":11.68,"timestamp":1789762204697,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.27163905691128976},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRXA\",,,,,undefined,":{"symbol":"VRXA","floatShares":40957496,"roa":"-49.99%","roe":"-871.42%","lyrEps":-5.803658,"volumeRatio":0.27163905691128976,"shares":141407813,"dividePrice":0,"high":1.5152,"amplitude":0.044354,"preClose":1.47,"low":1.45,"week52Low":1.27,"pbRate":"-10.77","psRate":"7248.74","week52High":27.36,"institutionHeld":0,"latestPrice":1.46,"eps":0.2142,"divideRate":0,"volume":16375,"delay":0,"ttmEps":0.2142,"open":1.5,"prevYearClose":18.65,"prevWeekClose":1.65,"prevMonthClose":1.35,"prevQuarterClose":1.88,"fiveDayClose":1.65,"twentyDayClose":1.89,"sixtyDayClose":2.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VRXA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VRXA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VRXA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VRXA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VRXA","date":"2026-09-18","current":6.81606,"percent":0.45,"low":-3.022108,"twenty":-2.751957,"median":-2.365287,"eighty":-1.181392,"high":-0.413162,"avg":-1.904414,"sd":0.904601,"marketCap":207869485},"quantilePoints":[{"date":"2026-08-21","current":-1.35335,"twenty":-1.349054,"median":-1.34261,"eighty":-1.336165,"marketCap":47660725},{"date":"2026-08-28","current":-1.03732,"twenty":-1.349054,"median":-1.281094,"eighty":-1.194963,"marketCap":36312933},{"date":"2026-09-04","current":-2.622384,"twenty":-1.391748,"median":-1.265172,"eighty":-0.552029,"marketCap":216353953},{"date":"2026-09-11","current":-2.842124,"twenty":-2.738773,"median":-1.34261,"eighty":-1.03732,"marketCap":233322891},{"date":"2026-09-18","current":-2.57236,"twenty":-2.751957,"median":-2.365287,"eighty":-1.181392,"marketCap":207869485}],"updateTime":1789856073996},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VRXA\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668492097","title":"VERAXA Biotech (NASDAQ: VRXA) Adds Capital Markets Veteran as CFO While Advancing BiTAC Oncology Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2668492097","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668492097?lang=en_us&edition=fundamental","pubTime":"2026-09-19 02:31","pubTimestamp":1789756268,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, September 18th, 2026, FinanceWire VERAXA has appointed Raju Willener as Chief Financial Officer, effective immediatel...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-adds-capital-markets-veteran-as-cfo-while-advancing-bitac-oncology-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-adds-capital-markets-veteran-as-cfo-while-advancing-bitac-oncology-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIW.SI","ONEQ","QQQY","TECS",".IXIC","03086","MNQmain","QQQA","NQmain","BK4581","QDTE","NDX","FTEC","QQQM","GPIQ","QYLG","TQQY","QQQJ","JEPQ","IYW","TQQQ","XBI","QQQ","QLD","QID","PSQ","BK4139","SQQQ","BK4588","QQQE","VRXA","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668987897","title":"VERAXA Biotech (NASDAQ: VRXA) Building a New Approach to Precision Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2668987897","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668987897?lang=en_us&edition=fundamental","pubTime":"2026-09-17 00:30","pubTimestamp":1789576207,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, September 16th, 2026, FinanceWire VERAXA is developing antibody-based cancer therapies aimed at improving the therape...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-building-a-new-approach-to-precision-cancer-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-building-a-new-approach-to-precision-cancer-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNQmain","03086","ONEQ","XBI","QQQM","BK4588","QQQJ","BK4585","BK4581","NQmain","QQQA","QQQY","QLD","TECS",".IXIC","SQQQ","TQQQ","FTEC","QQQE","GPIQ","QID","TQQY","NDX","JEPQ","NVIW.SI","QDTE","VRXA","QYLG","QQQ","PSQ","BK4139","IYW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667069304","title":"Veraxa Biotech Files Initial Beneficial Ownership Statement for CFO Raju Sudir Willener","url":"https://stock-news.laohu8.com/highlight/detail?id=2667069304","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667069304?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:10","pubTimestamp":1789416652,"startTime":"0","endTime":"0","summary":"Veraxa Biotech files initial beneficial ownership statement for CFO Raju Sudir WillenerVeraxa Biotech filed an initial Form 3 disclosing Chief Financial Officer Raju Sudir Willener as a reporting insi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL3s2Bxc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRXA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664336297","title":"Veraxa Biotech Names Raju Willener as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2664336297","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664336297?lang=en_us&edition=fundamental","pubTime":"2026-09-04 19:00","pubTimestamp":1788519621,"startTime":"0","endTime":"0","summary":"Veraxa Biotech names Raju Willener as CFOVeraxa Biotech appointed Raju Willener as chief financial officer, effective immediately, reporting to CEO Christoph Antz.Willener previously served as directo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL15nJ5k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","SG9999014021.USD","SG9999014005.SGD","BCDF","BK4588","IE00BN0W2W23.USD","LU2095319765.USD","SG9999014013.SGD","IE00BQXX3C00.GBP","BK4112","LU0314104364.USD","IE00BGHQF748.EUR","IE00BQXX3F31.USD","NDAQ","LU2210150020.SGD","IE00B3QW5Z07.USD","LU2210149790.SGD","SG9999014039.USD","IE00BN0W2V16.EUR","VRXA","BK4139","IE00BQXX3D17.EUR","BK4585","IE00BN0W2T93.GBP","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":19,"pageCount":1,"totalSize":74,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/VRXA\",params:#limit:6,delay:false,,,undefined,":[]}}